Logo image of DHAI

DIH HOLDINGS US INC (DHAI) Stock Fundamental Analysis

NASDAQ:DHAI - Nasdaq - US23290B1061 - Common Stock - Currency: USD

0.22  0 (-0.45%)

Premarket: 0.2172 0 (-1.27%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DHAI. DHAI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of DHAI have multiple concerns. DHAI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DHAI was profitable.
DHAI had a negative operating cash flow in the past year.
DHAI Yearly Net Income VS EBIT VS OCF VS FCFDHAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M 4M 6M

1.2 Ratios

DHAI's Return On Assets of 1.45% is fine compared to the rest of the industry. DHAI outperforms 74.87% of its industry peers.
The Return On Equity of DHAI (1.80%) is better than 75.40% of its industry peers.
Industry RankSector Rank
ROA 1.45%
ROE 1.8%
ROIC N/A
ROA(3y)1.29%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DHAI Yearly ROA, ROE, ROICDHAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 2 -2

1.3 Margins

DHAI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DHAI Yearly Profit, Operating, Gross MarginsDHAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, DHAI has about the same amount of shares outstanding.
DHAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DHAI Yearly Shares OutstandingDHAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
DHAI Yearly Total Debt VS Total AssetsDHAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

DHAI has an Altman-Z score of 0.02. This is a bad value and indicates that DHAI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DHAI (0.02) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.03 indicates that DHAI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, DHAI is in the better half of the industry, outperforming 64.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0.02
ROIC/WACCN/A
WACCN/A
DHAI Yearly LT Debt VS Equity VS FCFDHAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.02 indicates that DHAI may have some problems paying its short term obligations.
DHAI has a worse Current ratio (0.02) than 99.47% of its industry peers.
DHAI has a Quick Ratio of 0.02. This is a bad value and indicates that DHAI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.02, DHAI is doing worse than 99.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
DHAI Yearly Current Assets VS Current LiabilitesDHAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100K 200K 300K 400K

More info and screens

0

3. Growth

3.1 Past

DHAI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.11%.
EPS 1Y (TTM)-1.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 2.44 indicates a rather cheap valuation of DHAI.
Based on the Price/Earnings ratio, DHAI is valued cheaply inside the industry as 98.93% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.57. DHAI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.44
Fwd PE N/A
DHAI Price Earnings VS Forward Price EarningsDHAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DHAI Per share dataDHAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DHAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIH HOLDINGS US INC

NASDAQ:DHAI (6/16/2025, 8:00:01 PM)

Premarket: 0.2172 0 (-1.27%)

0.22

0 (-0.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.08%
Inst Owner Change485.38%
Ins Owners0.45%
Ins Owner Change0%
Market Cap10.41M
AnalystsN/A
Price TargetN/A
Short Float %5.02%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.44
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA N/A
EPS(TTM)0.09
EY40.91%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.98
TBVpS0.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 1.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.29%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 0.02
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)102.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.36%
OCF growth 3YN/A
OCF growth 5YN/A